SCHEMBL15319360

SCHEMBL15319360

CCOc1cccc2c1CCOC2C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.43
GLA P06280 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ACHE P22303 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20480080 0.85 ADRA2A (0.49) L3MBTL1MEN1KMT2AMAPTKDM4E
SCHEMBL20482712 0.85 ADRA2A (0.49) L3MBTL1MEN1KMT2AMAPTKDM4E
SCHEMBL30436776 0.85 ADRA2A (0.49) L3MBTL1MEN1KMT2AMAPTKDM4E
SCHEMBL15320257 0.77 RAB9A (0.40) FFAR1MEN1KMT2AALDH1A1ADRA2A
SCHEMBL16534543 0.77 ADRA2A (0.45) FFAR1MEN1KMT2AMAPTKDM4E
SCHEMBL22491683 0.77 ADRA2A (0.45) FFAR1MEN1KMT2AMAPTKDM4E
SCHEMBL30436522 0.77 ADRA2A (0.45) FFAR1MEN1KMT2AMAPTKDM4E
SCHEMBL24543430 0.76 HTR2C (0.39) FFAR1KMT2AALDH1A1HTR2C
Toluene SCHEMBL22466777 0.75 ALDH1A1 (0.42) FFAR1MEN1KMT2AKDM4EALDH1A1
SCHEMBL8807888 0.75 FFAR1 (0.47) FFAR1MEN1KMT2APTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2834233-B1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORP (FI) 2018-04-25 EP disclosed
US-9249127-B2 Alpha2 adrenoceptor agonists ORION CORPORATION (FI) 2016-02-02 US disclosed
US-20150065550-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORPORATION (FI) 2015-03-05 US disclosed
EP-2834233-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS Orion Corporation (FI) 2015-02-11 EP disclosed
WO-2013150173-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORPORATION (FI) 2013-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065550-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ADRA2A, ADRB2, ADRA2C FFAR1 165/4885GLA 1419/4885L3MBTL1 3591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.